Clinical scenario
A 58-year-old male with hypertension and diastolic heart failure on metoprolol 100 mg daily was brought to the emergency department 20 minutes after consuming a shrimp-containing meal at a restaurant. Symptoms began with throat tightness and lip swelling progressing to dyspnoea and presyncope. No urticaria was observed. He received 0.3 mg intramuscular adrenaline in the thigh by paramedics prior to arrival. On arrival he remains hypotensive with inadequate response to adrenaline.
Clinical examination
Blood pressure 72/40 mmHg - heart rate 58 bpm - respiratory rate 24/min - SpO2 89% on room air. The patient is pale diaphoretic and obtunded. Jugular veins are non-distended. Faint bilateral basal wheeze. Marked lip and tongue swelling. No urticaria. Cold and mottled extremities.
Labs & imaging
Full blood count normal. Sodium 138 chloride 101 potassium 4.2 mmol/L. Creatinine 1.1 mg/dL. Glucose 7.8 mmol/L. ECG: sinus bradycardia at 58 bpm with no ST changes. Initial troponin negative. Arterial blood gas: pH 7.28 PaCO2 48 PaO2 62 HCO3 21.
In this patient with adrenaline-refractory anaphylactic shock who is receiving a beta-blocker - what is the optimal next pharmacological intervention according to physiological rationale and clinical guidelines?
Correct answer is C - glucagon in beta-blocker-associated refractory anaphylactic shock | Differential diagnosis includes: distributive shock from insufficient adrenaline versus cardiogenic shock versus true anaphylaxis with beta-blocker effect | The decisive feature is unexpected bradycardia in the context of acute shock with a metoprolol history - this pattern indicates that beta-blockade is suppressing the normal adrenergic response | Work-up logic: adrenaline acts via alpha and beta receptors - beta-blockade abolishes the chronotropic and inotropic response explaining persistent hypotension with bradycardia | Glucagon acts via beta-receptor-independent pathways directly raising intracellular cAMP in cardiac cells thereby bypassing the blockade and improving cardiac output | Results interpretation: pH 7.28 reflects metabolic acidosis from tissue hypoperfusion - SpO2 89% with wheeze indicates a respiratory component | Initial management: intramuscular adrenaline first then aggressive IV fluids in parallel with glucagon when response is inadequate - intravenous adrenaline is reserved for monitored settings only | When to observe: no role for observation in true shock | When to start treatment: immediately with glucagon and fluids | When to admit: immediate ICU admission | When it is an emergency: now - shock with deteriorating respiratory status and impending loss of consciousness | When to escalate airway/ICU: at SpO2 below 88% or altered consciousness or glucagon failure | Surgery: not indicated | Complications: myocardial ischaemia from hypoperfusion - acute kidney injury - hypoxic encephalopathy | Red flags: bradycardia with shock in a patient on beta-blockers | Clinical pitfalls: the common error is repeating adrenaline alone without addressing the mechanism of resistance - corticosteroid as first-line is a dangerous mistake - antihistamines do not treat haemodynamic shock | Follow-up and referral: refer to allergist after recovery to identify the trigger assess need for adrenaline autoinjector and re-evaluate metoprolol as a risk-amplifying cofactor | Consultant pearl: bradycardia in anaphylactic shock equals beta-blockade until proven otherwise - glucagon is the physiologically correct antidote